Value through Innovation

main navigation

jump to content to meta navigation
Headillu

page content

jump to main navigation to meta navigation

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
25.10.2007 New three-year data confirms Aptivus® (tipranavir) as effective and durable treatment option for treatment-experienced patients - For medical media, outside the US only
16.10.2007 New data suggests doctors might not be considering depression symptoms that are important to patients, such as pain and anxiety
15.10.2007 Vitae Pharmaceuticals and Boehringer Ingelheim announce a major collaboration to develop and commercialize novel treatments for diabetes and metabolic diseases
12.10.2007 Boehringer Ingelheim distinguished as number one Top Employer 2007 by Science Magazine
05.10.2007 Aptivus® (tipranavir) capsules granted full approval by the U.S. FDA
01.10.2007 Boehringer Ingelheim comments the nevirapine production for Rwanda by Apotex - For medical media, outside the US only
17.09.2007 ERS COPD Research Awards 2007
Sponsored by Boehringer Ingelheim
The two winners come from Denmark and Italy
14.09.2007 The Lancet publishes major study of Boehringer Ingelheim´s novel oral direct thrombin inhibitor dabigatran etexilate - For medical media, outside the US only
07.09.2007 Ablynx and Boehringer Ingelheim announce major global strategic alliance to discover, develop and commercialise novel nanobody® therapeutics
06.09.2007 Boehringer Ingelheim to initiate first Phase III pivotal study for new oncology compound BIBW 2992 - For medical media, outside the US only
04.09.2007 Prehospital thrombolysis for AMI to be studied in new clinical trial - For scientific media outside the USA, Canada and Japan
31.08.2007 Boehringer Ingelheim voluntarily withdraws its clobutinol containing medications
28.08.2007 PRODEST study shows many Parkinson’s disease (PD) patients continue to experience PD-related depressive symptoms despite receiving anti-depressant treatment - For medical media, outside the US only
26.07.2007 Key business with prescription medicines continues to boost growth at Boehringer Ingelheim
25.07.2007 New Spiriva® Respimat® inhaler completes European approval process for COPD
25.07.2007 Data presented at International AIDS Society (IAS) conference shows long-term Viramune ® (nevirapine) efficacy and increase in good cholesterol - For medical media, outside the US only
24.07.2007 Boehringer Ingelheim announces first international head-to-head trial of Aptivus® (tipranavir) versus darunavir in treatment-experienced HIV-positive patients - For medical media, outside the US only
24.07.2007 Aptivus® (tipranavir) demonstrates potent and durable treatment response in HIV-positive women - For medical media, outside the US only
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
back to top

Contact

Boehringer Ingelheim GmbH

Corporate Headquarters
Binger Str. 173
55216 Ingelheim
Germany


Phone +49 / 6132 / 77 0
Fax +49 / 6132 / 72 0

media contacts

RSS feeds allow you to receive latest news and information about Boehringer Ingelheim.

subscribe to RSS Feed